You just read:

Haemonetics Reports 10% Revenue Growth for Fourth Quarter of Fiscal 2012 and $0.80 Adjusted EPS; Also Establishes Fiscal 2013 Guidance

News provided by

Haemonetics Corporation

Apr 29, 2012, 12:04 ET